Mereo BioPharma (MREO) Current Leases (2018 - 2025)
Mereo BioPharma (MREO) reported Current Leases of $202000.0 for Q4 2025, down 71.43% year-over-year from $707000.0 in Q4 2024, and down 49.12% quarter-over-quarter from $397000.0 in Q3 2025.
Mereo BioPharma (MREO) Current Leases (2018 - 2025) Analysis & Trends
Mereo BioPharma (MREO) has 8 years of Current Leases data on file, last reported at $202000.0 in Q4 2025.
- Current Leases for Q4 2025 came in at $202000.0, down 71.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $202000.0 (down 71.43% YoY), and the FY2025 annual result was $202000.0, down 71.43% from the prior year.
- Current Leases eased to $202000.0 in Q4 2025 per MREO's latest filing, from $397000.0 in the prior quarter.
- Over five years, Current Leases peaked at $838462.6 in Q4 2021 and troughed at $202000.0 in Q4 2025.
- A 5-year average of $615277.0 and a median of $662000.0 in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2025: Current Leases rose 19.29% in 2023, then tumbled 71.43% in 2025.
- A 5-year view of Current Leases shows it stood at $838462.6 in 2021, then plunged by 34.81% to $546584.6 in 2022, then climbed by 19.29% to $652000.0 in 2023, then advanced by 8.44% to $707000.0 in 2024, then plunged by 71.43% to $202000.0 in 2025.
- Business Quant data shows MREO's Current Leases at $202000.0 in Q4 2025, $397000.0 in Q3 2025, and $601000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 202,000.00 |
| Sep 30, 2025 | 397,000.00 |
| Jun 30, 2025 | 601,000.00 |
| Mar 31, 2025 | 747,000.00 |
| Dec 31, 2024 | 707,000.00 |
| Sep 30, 2024 | 736,000.00 |
| Jun 30, 2024 | 679,000.00 |
| Mar 31, 2024 | 662,000.00 |
| Dec 31, 2023 | 652,000.00 |
| Dec 31, 2022 | 546,584.60 |
| Dec 31, 2021 | 838,462.60 |
| Dec 31, 2020 | 839,806.84 |
| Dec 31, 2019 | 3.32 Mn |
| Dec 31, 2018 | 781,067.71 |